State Of Wisconsin Investment Board Cel Sci Corp Transaction History

State Of Wisconsin Investment Board

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$7.1 - $12.82 $332,990 - $601,258	-46,900 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$7.64 - $12.49 $108,488 - $177,358	-14,200 Reduced 23.24%	46,900 $515,000
Q2 2021 Aug 12, 2021	SELL	$8.68 - $27.49 $50,344 - $159,442	-5,800 Reduced 8.67%	61,100 $530,000
Q1 2021 May 17, 2021	SELL	$12.0 - $27.64 $39,600 - $91,212	-3,300 Reduced 4.7%	66,900 $1.02 Million
Q4 2020 Feb 03, 2021	SELL	$11.05 - $16.62 $92,820 - $139,608	-8,400 Reduced 10.69%	70,200 $819,000
Q3 2020 Nov 16, 2020	BUY	$11.69 - $14.54 $254,842 - $316,972	21,800 Added 38.38%	78,600 $1 Million
Q2 2020 Aug 12, 2020	BUY	$9.75 - $17.6 $58,500 - $105,600	6,000 Added 11.81%	56,800 $847,000
Q1 2020 May 06, 2020	BUY	$7.54 - $17.05 $85,202 - $192,665	11,300 Added 28.61%	50,800 $586,000
Q3 2019 Nov 12, 2019	BUY	$6.0 - $9.6 $237,000 - $379,200	39,500 New	39,500 $353,000

27.1K

150K

Ticker CVM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,367,500
Market Cap $30.4M
Description
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.